India vs Nigeria: Cause of death, by non-communicable diseases, ages 15-59, male
India
42.1%
in 2021
Nigeria
42.2%
in 2021
India rank
124th
Nigeria rank
122nd
Cause of death, by non-communicable diseases, ages 15-59, male over time
- India
- Nigeria
How they compare
Nigeria currently reports 42.2% against 42.1% in India, a difference of 0.1%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was India ahead.
India ranks 124th and Nigeria ranks 122nd of 185 countries.
India has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | India | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 42.2% | 30.1% | 12.1% | India |
| 2010s | 57.7% | 36.2% | 21.5% | India |
| 2020s | 49.8% | 40.3% | 9.4% | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, India or Nigeria?
- Nigeria, at 42.2% against 42.1% in India as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between India and Nigeria?
- 0.1%, with Nigeria ahead.
- How many years of comparable data are there for India and Nigeria?
- 6 years are reported by both, from 2000 to 2021.
- How do India and Nigeria rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- India ranks 124th and Nigeria ranks 122nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.